Ernestas Rinkevičius1, Dominyka Surgontaitė1, Justas Balčiūnas1
1Lithuanian University of Health Sciences. Academy of Medicine. Faculty of Medicine.
Lung cancer is one of the most common malignancies in the world. Mortality rate of this disease remains evidently high. In most frequent cases, lung cancer is diagnosed in its late stage, when it is metastasized and hard to control. Lung cancer screening could lead to better management and outcomes. Low-dose computed tomography (LDCT) is one of the most important screening methods. It should be used on certain patients, that are of higher risk of developing this malignancy. False positive results are a frequent flaw of LDCT and one of the reasons for unnecessary lung biopsies. In order to obtain the greatest benefit it is important to have certain guidelines. Our aim in this review is to find and summarise the newest recommendations in lung cancer screening with LDCT.
Keywords: lung cancer, earl diagnosis, low dose CT.